ArticleClinical and experimental immunology1989

The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.

H D Volk et al.PubMed ↗Full text ↗

No numbers read from the abstract.